img

Global CAR T-Cell-Based Drug Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global CAR T-Cell-Based Drug Market Research Report 2024

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
According to Mr Accuracy reports’s new survey, global CAR T-Cell-Based Drug market is projected to reach US$ 19190 million in 2029, increasing from US$ 2806 million in 2022, with the CAGR of 29.4% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole CAR T-Cell-Based Drug market research.
The CAR T-cell-based drug market is driven by the growing demand for innovative and targeted cancer therapies. Chimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary approach that involves genetically modifying a patient's T cells to recognize and attack cancer cells. The success of CAR T-cell therapies in treating certain types of blood cancers, such as leukemia and lymphoma, has fueled market growth and encouraged research into expanding the application of CAR T-cell therapy to other solid tumor malignancies. However, the market also faces challenges, including the high cost of CAR T-cell therapy and the complexity of the manufacturing process, which may limit patient access. Additionally, the potential for severe side effects and the need for patient selection and management pose regulatory and clinical challenges. To succeed, companies must focus on advancing research, streamlining the production process, collaborating with healthcare providers to improve patient access and support, and addressing safety and efficacy concerns to establish CAR T-cell-based drugs as a transformative treatment option for cancer patients.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CAR T-Cell-Based Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Segment by Type
CD19-targeted
BCMA-targeted

Segment by Application


Lymphoma
Multiple Myeloma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The CAR T-Cell-Based Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-Cell-Based Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 CD19-targeted
1.2.3 BCMA-targeted
1.3 Market by Application
1.3.1 Global CAR T-Cell-Based Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR T-Cell-Based Drug Market Perspective (2018-2029)
2.2 CAR T-Cell-Based Drug Growth Trends by Region
2.2.1 Global CAR T-Cell-Based Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 CAR T-Cell-Based Drug Historic Market Size by Region (2018-2024)
2.2.3 CAR T-Cell-Based Drug Forecasted Market Size by Region (2024-2029)
2.3 CAR T-Cell-Based Drug Market Dynamics
2.3.1 CAR T-Cell-Based Drug Industry Trends
2.3.2 CAR T-Cell-Based Drug Market Drivers
2.3.3 CAR T-Cell-Based Drug Market Challenges
2.3.4 CAR T-Cell-Based Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR T-Cell-Based Drug Players by Revenue
3.1.1 Global Top CAR T-Cell-Based Drug Players by Revenue (2018-2024)
3.1.2 Global CAR T-Cell-Based Drug Revenue Market Share by Players (2018-2024)
3.2 Global CAR T-Cell-Based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CAR T-Cell-Based Drug Revenue
3.4 Global CAR T-Cell-Based Drug Market Concentration Ratio
3.4.1 Global CAR T-Cell-Based Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell-Based Drug Revenue in 2022
3.5 CAR T-Cell-Based Drug Key Players Head office and Area Served
3.6 Key Players CAR T-Cell-Based Drug Product Solution and Service
3.7 Date of Enter into CAR T-Cell-Based Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-Cell-Based Drug Breakdown Data by Type
4.1 Global CAR T-Cell-Based Drug Historic Market Size by Type (2018-2024)
4.2 Global CAR T-Cell-Based Drug Forecasted Market Size by Type (2024-2029)
5 CAR T-Cell-Based Drug Breakdown Data by Application
5.1 Global CAR T-Cell-Based Drug Historic Market Size by Application (2018-2024)
5.2 Global CAR T-Cell-Based Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America CAR T-Cell-Based Drug Market Size (2018-2029)
6.2 North America CAR T-Cell-Based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America CAR T-Cell-Based Drug Market Size by Country (2018-2024)
6.4 North America CAR T-Cell-Based Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR T-Cell-Based Drug Market Size (2018-2029)
7.2 Europe CAR T-Cell-Based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe CAR T-Cell-Based Drug Market Size by Country (2018-2024)
7.4 Europe CAR T-Cell-Based Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR T-Cell-Based Drug Market Size (2018-2029)
8.2 Asia-Pacific CAR T-Cell-Based Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific CAR T-Cell-Based Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific CAR T-Cell-Based Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CAR T-Cell-Based Drug Market Size (2018-2029)
9.2 Latin America CAR T-Cell-Based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America CAR T-Cell-Based Drug Market Size by Country (2018-2024)
9.4 Latin America CAR T-Cell-Based Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR T-Cell-Based Drug Market Size (2018-2029)
10.2 Middle East & Africa CAR T-Cell-Based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa CAR T-Cell-Based Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa CAR T-Cell-Based Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis CAR T-Cell-Based Drug Introduction
11.1.4 Novartis Revenue in CAR T-Cell-Based Drug Business (2018-2024)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences CAR T-Cell-Based Drug Introduction
11.2.4 Gilead Sciences Revenue in CAR T-Cell-Based Drug Business (2018-2024)
11.2.5 Gilead Sciences Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Introduction
11.3.4 Bristol-Myers Squibb Revenue in CAR T-Cell-Based Drug Business (2018-2024)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 J & J
11.4.1 J & J Company Detail
11.4.2 J & J Business Overview
11.4.3 J & J CAR T-Cell-Based Drug Introduction
11.4.4 J & J Revenue in CAR T-Cell-Based Drug Business (2018-2024)
11.4.5 J & J Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Detail
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics CAR T-Cell-Based Drug Introduction
11.5.4 JW Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2024)
11.5.5 JW Therapeutics Recent Development
11.6 FOSUNKite
11.6.1 FOSUNKite Company Detail
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite CAR T-Cell-Based Drug Introduction
11.6.4 FOSUNKite Revenue in CAR T-Cell-Based Drug Business (2018-2024)
11.6.5 FOSUNKite Recent Development
11.7 CARsgen Therapeutics
11.7.1 CARsgen Therapeutics Company Detail
11.7.2 CARsgen Therapeutics Business Overview
11.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Introduction
11.7.4 CARsgen Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2024)
11.7.5 CARsgen Therapeutics Recent Development
11.8 Autolus Therapeutics
11.8.1 Autolus Therapeutics Company Detail
11.8.2 Autolus Therapeutics Business Overview
11.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Introduction
11.8.4 Autolus Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2024)
11.8.5 Autolus Therapeutics Recent Development
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Detail
11.9.2 Sorrento Therapeutics Business Overview
11.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Introduction
11.9.4 Sorrento Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2024)
11.9.5 Sorrento Therapeutics Recent Development
11.10 Mustang Bio
11.10.1 Mustang Bio Company Detail
11.10.2 Mustang Bio Business Overview
11.10.3 Mustang Bio CAR T-Cell-Based Drug Introduction
11.10.4 Mustang Bio Revenue in CAR T-Cell-Based Drug Business (2018-2024)
11.10.5 Mustang Bio Recent Development
11.11 Bluebird Bio
11.11.1 Bluebird Bio Company Detail
11.11.2 Bluebird Bio Business Overview
11.11.3 Bluebird Bio CAR T-Cell-Based Drug Introduction
11.11.4 Bluebird Bio Revenue in CAR T-Cell-Based Drug Business (2018-2024)
11.11.5 Bluebird Bio Recent Development
11.12 Cellectis
11.12.1 Cellectis Company Detail
11.12.2 Cellectis Business Overview
11.12.3 Cellectis CAR T-Cell-Based Drug Introduction
11.12.4 Cellectis Revenue in CAR T-Cell-Based Drug Business (2018-2024)
11.12.5 Cellectis Recent Development
11.13 Allogene Therapeutics
11.13.1 Allogene Therapeutics Company Detail
11.13.2 Allogene Therapeutics Business Overview
11.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Introduction
11.13.4 Allogene Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2024)
11.13.5 Allogene Therapeutics Recent Development
11.14 Celyad
11.14.1 Celyad Company Detail
11.14.2 Celyad Business Overview
11.14.3 Celyad CAR T-Cell-Based Drug Introduction
11.14.4 Celyad Revenue in CAR T-Cell-Based Drug Business (2018-2024)
11.14.5 Celyad Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CAR T-Cell-Based Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of CD19-targeted
Table 3. Key Players of BCMA-targeted
Table 4. Global CAR T-Cell-Based Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global CAR T-Cell-Based Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global CAR T-Cell-Based Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global CAR T-Cell-Based Drug Market Share by Region (2018-2024)
Table 8. Global CAR T-Cell-Based Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global CAR T-Cell-Based Drug Market Share by Region (2024-2029)
Table 10. CAR T-Cell-Based Drug Market Trends
Table 11. CAR T-Cell-Based Drug Market Drivers
Table 12. CAR T-Cell-Based Drug Market Challenges
Table 13. CAR T-Cell-Based Drug Market Restraints
Table 14. Global CAR T-Cell-Based Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global CAR T-Cell-Based Drug Market Share by Players (2018-2024)
Table 16. Global Top CAR T-Cell-Based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell-Based Drug as of 2022)
Table 17. Ranking of Global Top CAR T-Cell-Based Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by CAR T-Cell-Based Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CAR T-Cell-Based Drug Product Solution and Service
Table 21. Date of Enter into CAR T-Cell-Based Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CAR T-Cell-Based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global CAR T-Cell-Based Drug Revenue Market Share by Type (2018-2024)
Table 25. Global CAR T-Cell-Based Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global CAR T-Cell-Based Drug Revenue Market Share by Type (2024-2029)
Table 27. Global CAR T-Cell-Based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global CAR T-Cell-Based Drug Revenue Market Share by Application (2018-2024)
Table 29. Global CAR T-Cell-Based Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global CAR T-Cell-Based Drug Revenue Market Share by Application (2024-2029)
Table 31. North America CAR T-Cell-Based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America CAR T-Cell-Based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America CAR T-Cell-Based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe CAR T-Cell-Based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe CAR T-Cell-Based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe CAR T-Cell-Based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific CAR T-Cell-Based Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific CAR T-Cell-Based Drug Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific CAR T-Cell-Based Drug Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America CAR T-Cell-Based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America CAR T-Cell-Based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America CAR T-Cell-Based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa CAR T-Cell-Based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa CAR T-Cell-Based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa CAR T-Cell-Based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Novartis Company Detail
Table 47. Novartis Business Overview
Table 48. Novartis CAR T-Cell-Based Drug Product
Table 49. Novartis Revenue in CAR T-Cell-Based Drug Business (2018-2024) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Gilead Sciences Company Detail
Table 52. Gilead Sciences Business Overview
Table 53. Gilead Sciences CAR T-Cell-Based Drug Product
Table 54. Gilead Sciences Revenue in CAR T-Cell-Based Drug Business (2018-2024) & (US$ Million)
Table 55. Gilead Sciences Recent Development
Table 56. Bristol-Myers Squibb Company Detail
Table 57. Bristol-Myers Squibb Business Overview
Table 58. Bristol-Myers Squibb CAR T-Cell-Based Drug Product
Table 59. Bristol-Myers Squibb Revenue in CAR T-Cell-Based Drug Business (2018-2024) & (US$ Million)
Table 60. Bristol-Myers Squibb Recent Development
Table 61. J & J Company Detail
Table 62. J & J Business Overview
Table 63. J & J CAR T-Cell-Based Drug Product
Table 64. J & J Revenue in CAR T-Cell-Based Drug Business (2018-2024) & (US$ Million)
Table 65. J & J Recent Development
Table 66. JW Therapeutics Company Detail
Table 67. JW Therapeutics Business Overview
Table 68. JW Therapeutics CAR T-Cell-Based Drug Product
Table 69. JW Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2024) & (US$ Million)
Table 70. JW Therapeutics Recent Development
Table 71. FOSUNKite Company Detail
Table 72. FOSUNKite Business Overview
Table 73. FOSUNKite CAR T-Cell-Based Drug Product
Table 74. FOSUNKite Revenue in CAR T-Cell-Based Drug Business (2018-2024) & (US$ Million)
Table 75. FOSUNKite Recent Development
Table 76. CARsgen Therapeutics Company Detail
Table 77. CARsgen Therapeutics Business Overview
Table 78. CARsgen Therapeutics CAR T-Cell-Based Drug Product
Table 79. CARsgen Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2024) & (US$ Million)
Table 80. CARsgen Therapeutics Recent Development
Table 81. Autolus Therapeutics Company Detail
Table 82. Autolus Therapeutics Business Overview
Table 83. Autolus Therapeutics CAR T-Cell-Based Drug Product
Table 84. Autolus Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2024) & (US$ Million)
Table 85. Autolus Therapeutics Recent Development
Table 86. Sorrento Therapeutics Company Detail
Table 87. Sorrento Therapeutics Business Overview
Table 88. Sorrento Therapeutics CAR T-Cell-Based Drug Product
Table 89. Sorrento Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2024) & (US$ Million)
Table 90. Sorrento Therapeutics Recent Development
Table 91. Mustang Bio Company Detail
Table 92. Mustang Bio Business Overview
Table 93. Mustang Bio CAR T-Cell-Based Drug Product
Table 94. Mustang Bio Revenue in CAR T-Cell-Based Drug Business (2018-2024) & (US$ Million)
Table 95. Mustang Bio Recent Development
Table 96. Bluebird Bio Company Detail
Table 97. Bluebird Bio Business Overview
Table 98. Bluebird Bio CAR T-Cell-Based Drug Product
Table 99. Bluebird Bio Revenue in CAR T-Cell-Based Drug Business (2018-2024) & (US$ Million)
Table 100. Bluebird Bio Recent Development
Table 101. Cellectis Company Detail
Table 102. Cellectis Business Overview
Table 103. Cellectis CAR T-Cell-Based Drug Product
Table 104. Cellectis Revenue in CAR T-Cell-Based Drug Business (2018-2024) & (US$ Million)
Table 105. Cellectis Recent Development
Table 106. Allogene Therapeutics Company Detail
Table 107. Allogene Therapeutics Business Overview
Table 108. Allogene Therapeutics CAR T-Cell-Based Drug Product
Table 109. Allogene Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2024) & (US$ Million)
Table 110. Allogene Therapeutics Recent Development
Table 111. Celyad Company Detail
Table 112. Celyad Business Overview
Table 113. Celyad CAR T-Cell-Based Drug Product
Table 114. Celyad Revenue in CAR T-Cell-Based Drug Business (2018-2024) & (US$ Million)
Table 115. Celyad Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-Cell-Based Drug Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global CAR T-Cell-Based Drug Market Share by Type: 2022 VS 2029
Figure 3. CD19-targeted Features
Figure 4. BCMA-targeted Features
Figure 5. Global CAR T-Cell-Based Drug Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global CAR T-Cell-Based Drug Market Share by Application: 2022 VS 2029
Figure 7. Lymphoma Case Studies
Figure 8. Multiple Myeloma Case Studies
Figure 9. CAR T-Cell-Based Drug Report Years Considered
Figure 10. Global CAR T-Cell-Based Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global CAR T-Cell-Based Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global CAR T-Cell-Based Drug Market Share by Region: 2022 VS 2029
Figure 13. Global CAR T-Cell-Based Drug Market Share by Players in 2022
Figure 14. Global Top CAR T-Cell-Based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell-Based Drug as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by CAR T-Cell-Based Drug Revenue in 2022
Figure 16. North America CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America CAR T-Cell-Based Drug Market Share by Country (2018-2029)
Figure 18. United States CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe CAR T-Cell-Based Drug Market Share by Country (2018-2029)
Figure 22. Germany CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific CAR T-Cell-Based Drug Market Share by Region (2018-2029)
Figure 30. China CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America CAR T-Cell-Based Drug Market Share by Country (2018-2029)
Figure 38. Mexico CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa CAR T-Cell-Based Drug Market Share by Country (2018-2029)
Figure 42. Turkey CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia CAR T-Cell-Based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Novartis Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2024)
Figure 45. Gilead Sciences Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2024)
Figure 46. Bristol-Myers Squibb Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2024)
Figure 47. J & J Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2024)
Figure 48. JW Therapeutics Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2024)
Figure 49. FOSUNKite Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2024)
Figure 50. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2024)
Figure 51. Autolus Therapeutics Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2024)
Figure 52. Sorrento Therapeutics Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2024)
Figure 53. Mustang Bio Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2024)
Figure 54. Bluebird Bio Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2024)
Figure 55. Cellectis Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2024)
Figure 56. Allogene Therapeutics Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2024)
Figure 57. Celyad Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries